Read + Share
Amedeo Smart
Independent Medical Education
Basta A, Lien K, Sun W, Whiting J, et al. A real-world single-center cohort study on the tolerability of trastuzumab deruxtecan for HER2+ metastatic breast cancer. Oncology 2025 Aug 4:1-18. doi: 10.1159/000547685.PMID: 40759100
Email
LinkedIn
Privacy Policy